Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results
Date:11/5/2010

nformation identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.Lexicon Pharmaceuticals, Inc.Selected Financial DataConsolidated Statements of Operations DataThree Months EndedSeptember 30,Nine Months Ended September 30,(In thousands, except per share data)2010200920102009(unaudited)(unaudited)Revenues:Collaborative research$  632$  1,650$  3,437$  8,042Subscription and license fees1494812181,246Total revenues7812,1313,6559,288Operating expenses:Research and development, including stock-based compensation

of $751, $733, $2,366 and $2,328, respectively20,08619,32061,41362,404General and administrative, including stock-based compensation

of $582, $547, $1,592 and $1,750, respectively4,9484,56815,53514,993Total operating expenses25,03423,88876,94877,397Loss from operations(24,253)(21,757)(73,293)(68,109)Gain on investments, net-1851411,008Interest income51103468669Interest expense(637)(785)(2,093)(2,180)Other expense, net(2,700)(516)(4,025)(2,037)Consolidated loss before taxes(27,539)(22,770)(78,802)(70,649)Income tax benefit2610226102Consolidated net loss(27,513)(22,668)(78,776)(70,547)Less: Net loss attributable to noncontrolling interest in Symphony Icon, Inc.-3,526-9,772Net loss attributable to Lexicon Pharmaceuticals, Inc.$  (27,513)$  (19,142)$  (78,776)$  (60,775)Net loss  attributable to Lexicon Pharmaceuticals, Inc. per common share, basic and diluted$   (0.08)$  (0.14)$  (0.27)$  (0.44)Shares used in computing net loss attributable to Lexicon Pharmaceuticals, Inc.  per common share, basic and diluted337,404137,
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Lexicon to Present at Stifel Nicolaus Healthcare Conference
2. Lexicon to Present at Morgan Stanley Global Healthcare Conference
3. Lexicon to Present at Two Major Healthcare Investor Conferences
4. Lexicon Announces Pricing of Common Stock in Public Offering
5. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
6. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
7. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
9. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
10. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
11. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... N.Y. , Aug. 21, 2014 ... launch of their Nutraceutical "TELO-20 for Dogs" with ... only Telomere-lengthening supplement in the world for dogs. ... of every chromosome in the body. A wealth ... leading experts in Telomere Science and Aging, including ...
(Date:8/21/2014)... Mathematic studies at the Program for Evolutionary ... by the Jeffrey Epstein VI Foundation , have shown ... identified for elimination. These aggressive cells are the driver mutations ... topological map of what to look for when examining tumors, ... tumor cells can be extracted from biopsy, it,s very difficult ...
(Date:8/21/2014)... , Aug. 21, 2014  Four-dimensional (4-D) ... behaviors based on external stimuli such as changes ... have a disruptive effect in multiple industries.  In ... business landscape by printing objects ranging from human ... automotive sectors. Logo - http://photos.prnewswire.com/prnh/20140820/138289 ...
(Date:8/21/2014)... MO (PRWEB) August 21, 2014 ... service biopharmaceutical contract development and manufacturing organization (CMO) ... Progenics Pharmaceuticals, Inc., an oncology company focused on ... treating cancer, to manufacture the anti-prostate specific membrane ... ADC product candidate. Under the agreement the ...
Breaking Biology Technology:Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3
... films ever made on a device the size of an ... could make it possible to build radically smaller storage devices ... devices. There,s just one obstacle on the way. Nano-sized magnets ... hairs above absolute zero. Now a chemistry student at the ...
... 2011 GeneWize Life Sciences, Inc., ... (OTCQB: GNLK), has announced the world,s first full-line ... and the first gene-modulating weight management supplement to complement ... Starting on March 12, GeneWize distributors were able to ...
... a new tool to help diagnose symptomatic patients with Herpes ... common sexually transmitted infections in the world.   ... announced today that it received U.S. Food and Drug Administration ... to detect and differentiate HSV types 1 and 2 in ...
Cached Biology Technology:Heavy metals open path to high temperature nanomagnets 2GeneWize Expands DNA Customization into 3 Mega Markets 2GeneWize Expands DNA Customization into 3 Mega Markets 3BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens 2
(Date:8/21/2014)... intake, health and quality of life of older adults ... the University of Waterloo receiving close to $1.5 million ... (CIHR). , Professor Heather Keller, of the Faculty ... research chair in nutrition and aging, will receive $979,000 ... in long-term care homes are poorly nourished. The project ...
(Date:8/21/2014)... Strait is a key region in the global oceanic circulation. ... Svalbard warm Atlantic water flows to the north into the ... masses and sea ice push their way out of the ... Atlantic water cools here on its way to the north ... caused in this manner drives the global band of oceanic ...
(Date:8/21/2014)... journal Carcinogenesis by researchers at the University ... adenomatous polyposis coli (APC) in suppressing colorectal cancer ... , Lead author Kristi Neufeld, associate professor in the ... Biology program at the KU Cancer Center, has spent ... the various activities of APC, a protein whose functional ...
Breaking Biology News(10 mins):Grants will fund landmark aging research at Waterloo 2Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3
... differences account for some of the most of the spectacular ... plumage of peacocks, tusks on walruses and antlers on moose. ... mating is thought to be a particularly potent force ... females. However, the genetic processes responsible for producing such ...
... PAUL (05/03/2012) Vegetation, such as a patch of prairie or ... when more plant species are present, a new University of ... found that each species plays a role in maintaining a ... The study found that every additional species in a plot ...
... of California, Berkeley, scientists are drilling into ancient sediments ... clues that could help them better predict how today,s ... increasing population. The lake sediments are among the ... as far as 500,000 years. The core drilling ...
Cached Biology News:Biologists turn back the clock to understand evolution of sex differences 2Plant diversity is key to maintaining productive vegetation, U of M study shows 2Scientists core into California's Clear Lake to explore past climate change 2Scientists core into California's Clear Lake to explore past climate change 3Scientists core into California's Clear Lake to explore past climate change 4
BD Falcon insert HTS 96 well, square A-bottom with lid. PET membrane, sterile. (5/ca) Packaging: 5 / pack, 5 / case ...
... is a direct antibiotic-based selection system for ... colony survival, eliminating the need for costly ... provides close to 100% accuracy in recombinant ... for robot colony picking. This cloning kit ...
... software for the microscopy market by ... components and peripherals with powerful archiving, ... intuitive interface simplifies workflow and speeds ... powerful features such as image stitching, ...
Mouse monoclonal [IA-C6] to MHC Class II I Ab + Ad (FITC) ( Abpromise for all tested applications). Antigen: Tissue / cell preparation of Purified Mouse lymph node B cells...
Biology Products: